NCT03421834View on ClinicalTrials.gov

Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions
Ventricular TachycardiaIschemic Cardiomyopathy
Interventions
PROCEDURE

Catheter ablation of ventricular tachycardia

Catheter ablation with a uniform mapping system, procedural endpoint, and definition of acute procedural success.

DRUG

Optimal medical treatment

Optimal guidelines-based heart failure treatment and antiarrhythmic drugs. Antiarrhythmics will be avoided if possible in the ablation group.

Trial Locations (5)

1000

University Medical Centre Ljubljana - Cardiology department, Ljubljana

University Medical Centre Ljubljana - Cardiovascular surgery department, Ljubljana

3000

General Hospital Celje, Celje

6310

General Hospital Izola, Izola

HR-10000

Klinički bolnički centar Sestre Milosrdnice, Zagreb

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT03421834 - Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions | Biotech Hunter | Biotech Hunter